Kyung NAM Pharm
경남제약 · 053950
Health Care Pharmaceuticals · KOSDAQ
Market cap US$24.5M (₩33.8B)
Overview
Kyung NAM Pharm makes everyday consumer health products, most notably Lemona, a powdered vitamin supplement, alongside over-the-counter medicines, a placenta-based health drink, a throat-infection treatment, and an antifungal remedy.
Its products reach consumers through tens of thousands of pharmacies nationwide, as well as convenience stores, large supermarkets, and health-and-beauty retailers. Listed on KOSDAQ, Korea's small-cap board, the company earns the largest share of its revenue from its over-the-counter medicines segment, with general food and health-functional food lines making up most of the remainder.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$49.6M
- FY2024US$44.1M
- FY2025US$40.5M
Operating profit
- FY2023−US$4.9M
- FY2024−US$683.2K
- FY2025−US$1.3M
Net income
- FY2023−US$16.1M
- FY2024US$6.3M
- FY2025−US$6.5M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?